N-able to Host First Quarter Earnings Conference Call on May 8, 2025

N-able to Host First Quarter Earnings Conference Call on May 8, 2025

BURLINGTON, Mass.–(BUSINESS WIRE)–N-able, Inc. (NYSE:NABL), a global software company delivering a unified cyber resiliency platform to manage, secure, and recover, today announced that it will host a conference call to discuss its financial results for the first quarter of 2025 at 8:30 a.m. ET on May 8, 2025.

A live webcast of the call will be available on the N-able Investor Relations website at http://investors.n-able.com. A replay of the webcast will be available on a temporary basis shortly after the event. N-able will issue its earnings release highlighting its first quarter results prior to the start of the conference call on May 8, 2025.

About N-able

N‑able’s mission is to protect businesses against evolving cyberthreats with a unified cyber resiliency platform to manage, secure, and recover. Our scalable technology infrastructure includes AI-powered capabilities, market-leading third-party integrations, and the flexibility to employ technologies of choice—to transform workflows and deliver critical security outcomes. Our partner-first approach combines our products with experts, training, and peer-led events that empower our customers to be secure, resilient, and successful. n-able.com

© 2025 N-able, Inc. All rights reserved.

Source: N-able, Inc.

Category: Financial

Investors

Griffin Gyr

[email protected]

Media

Kim Cecchini

Phone: 202.391.5205

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Technology Security Other Technology Business Professional Services Software Networks Other Professional Services Artificial Intelligence

MEDIA:

Logo
Logo

Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

COLUMBUS, Ohio–(BUSINESS WIRE)–
Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company’s investor relations website at investor.mt.com.

METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

Adam Uhlman

Head of Investor Relations

METTLER TOLEDO

Direct: 614-438-4794

[email protected]

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Machine Tools, Metalworking & Metallurgy Engineering Health Chemicals/Plastics Medical Devices Manufacturing Other Manufacturing

MEDIA:

Logo
Logo

VTEX Announces the Results of its 2025 Annual General Meeting of Shareholders

VTEX Announces the Results of its 2025 Annual General Meeting of Shareholders

NEW YORK–(BUSINESS WIRE)–
VTEX (NYSE: VTEX), the backbone for connected commerce, announced today that the following matters were approved in its annual general meeting of shareholders (“AGM”) held on April 25, 2025:

  1. Proposal No. 1: to resolve, as an ordinary resolution, on the re-election of certain members of the Board of Directors;
  2. Proposal No. 2: to resolve, as an ordinary resolution, the transition of the Company’s financial reporting standards to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) from International Financial Reporting Standards (“IFRS”), beginning from the fiscal year commencing on January 1, 2025;
  3. Proposal No. 3: the ratification and approval of financial statements and the auditor’s report for the fiscal year ended December 31, 2024.

68,892,908 Class A shares and 80,766,730 Class B shares were represented at the AGM, in person or by proxy, which indicates 96.36% of the voting power of our share capital was represented.

AGM Results

The detailed results of the AGM were as follows:

1. To resolve, as an ordinary resolution, on the re-election of certain members of the Board of Directors.

 

Director

FOR

% FOR

AGAINST

% AGAINST

ABSTAIN

% ABSTAIN

1.1

Geraldo do Carmo Thomaz Júnior

861,782,763

98.31%

14,707,851

1.68%

1,574

0.00%

1.2

Mariano Gomide de Faria

861,761,157

98.31%

14,728,948

1.68%

2,084

0.00%

1.3

Alejandro Raul Scannapieco

873,822,262

99.69%

2,633,785

0.30%

36,139

0.00%

1.4

Benoit Jean-Claude Marie Fouilland

873,822,460

99.69%

2,633,775

0.30%

35,951

0.00%

1.5

Francisco Alvarez-Demalde

860,204,353

98.13%

16,027,356

1.83%

328,499

0.04%

2. To resolve, as an ordinary resolution, the transition of the Company’s financial reporting standards to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) from International Financial Reporting Standards (“IFRS”), beginning from the fiscal year commencing on January 1, 2025.

FOR

% FOR

AGAINST

% AGAINST

ABSTAIN

% ABSTAIN

876,541,587

100.00%

1,847

0.00%

16,774

0.00%

3. The ratification and approval of financial statements and the auditor’s report for the fiscal year ended December 31, 2024.

FOR

% FOR

AGAINST

% AGAINST

ABSTAIN

% ABSTAIN

 

875,542,949

99.88%

50,630

0.01%

966,629

0.11%

 

Final voting results on all matters voted on at the AGM will be filed on VTEX’s profile on EDGAR at www.sec.gov.

About VTEX

VTEX (NYSE: VTEX) is the commerce suite of choice for bold CIOs and CEOs globally, delivering transformative outcomes with unprecedented operational efficiency. By unifying a comprehensive ecosystem of solutions—including B2C, B2B, Sales App, Pick and Pack, Data Pipeline, Retail Media, and Security Shield—VTEX empowers brands and retailers to eliminate friction, foster collaboration, and accelerate growth. More than just software, VTEX is an agent of transformation, seamlessly connecting customers, partners, and developers to drive tangible business results. Trusted by 2.4 thousand global B2C and B2B customers, including Carrefour, Colgate, Sony, Stanley Black & Decker, and Whirlpool, VTEX supports 3.4 thousand active online stores across 43 countries (FY ended December 31, 2024). For more information, visit www.vtex.com.

Forward-looking Statements

This announcement contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1993, as amended, and Section 21E of the Securities Exchange of 1934, as amended. Statements contained herein that are not clearly historical in nature, including statements about the VTEX strategies and business plans, are forward-looking, and the words “anticipate,” “believe,” “continues,” “expect,” “estimate,” “intend,” ”strategy,” “project,” “target” and similar expressions and future or conditional verbs such as “will,” “would,” “should,” “could,” “might,” “can,” “may,” or similar expressions are generally intended to identify forward-looking statements.

VTEX may also make forward-looking statements in its periodic reports filed with the U.S. Securities and Exchange Commission, or the SEC, in press releases and other written materials and in oral statements made by its officers and directors. These forward-looking statements speak only as of the date they are made and are based on the VTEX’s current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond VTEX’s control. A number of factors and risks could cause actual results to differ materially from those contained in any forward-looking statement. Further information regarding these and other risks is included in VTEX filings with the SEC.

As a consequence, current plans, anticipated actions and future financial position and results of operations may differ significantly from those expressed in any forward-looking statements in this announcement. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented as there is no guarantee that expected events, trends or results will actually occur. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information or future events or for any other reason.

This announcement may also contain estimates and other information concerning our industry that are based on industry publications, surveys and forecasts. This information involves a number of assumptions and limitations, and we have not independently verified the accuracy or completeness of the information.

VTEX IR Contact

Julia Vater Fernández

VP of Investor Relations

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Technology Finance Fintech Electronic Commerce Professional Services Software Internet Supply Chain Management Retail Online Retail

MEDIA:

Logo
Logo

Okeanis Eco Tankers Corp. – Announcement of 2025 Annual Meeting of Shareholders

ATHENS, Greece, April 25, 2025 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), announced today that it has scheduled its Annual Meeting of Shareholders for May 30, 2025, at 11:00 a.m. Greek time (the “Annual Meeting”). The record date for determining shareholders entitled to participate at the Annual Meeting is April 22, 2025. The business of the Annual Meeting is to elect eight directors to serve until the next annual meeting of shareholders or until their successors are elected and qualified, and to ratify the appointment of Deloitte Certified Public Accountants S.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Annual Meeting documentation and instructions for voting are expected to be mailed to all shareholders of record on or about April 25, 2025, and will be furnished to the U.S. Securities and Exchange Commission (the “Commission”) and available on the Commission’s website at www.sec.gov.

Separately, as part of the Annual Meeting process, the Company announced today that the board of directors of the Company has been expanded to consist of eight persons from the previous seven person board of directors. The vacancy on the board of directors of the Company created by this change is proposed to be filled at the Annual Meeting, rather than by the remaining directors.

The Company has decided to nominate Mr. Dimitrios Papalexopoulos for election as a director, to fill this vacancy. Dimitrios Papalexopoulos is a business executive with experience in management, business development, operations and commercial marketing across media, publishing, technology and fast-moving consumer goods. He is currently and has been since 2022 the Managing Director of Kathimerines Ekdoseis, a media and publishing company, and publisher of prominent Greek newspaper Kathimerini. He was previously its Chief Business Officer from 2019 to 2021. Prior to joining Kathimerines Ekdoseis, Mr. Papalexopoulos held senior positions in business development, sales, and brand management in Google between 2011 and 2018 and in Procter & Gamble between 2007 and 2010. He holds a B.A. in International and European Economic Studies from the Athens University of Economics and Business, a B.Sc. in Business Administration from the American College of Greece, an M.Sc. in International Employment Relations and HR Management from the London School of Economics and Political Science (LSE), and an MBA from the Massachusetts Institute of Technology (MIT) under the Sloan Fellows Program. Mr. Papalexopoulos has been a member of the Governing Council of the Athens University of Economics and Business since 2023.

The Company’s executive management team will remain unchanged. They will continue to work closely with the Company’s board of directors.

Contacts

Company

Iraklis Sbarounis, CFO
Tel: +30 210 480 4200
[email protected]

Investor Relations / Media Contact

Nicolas Bornozis, President
Capital Link, Inc.
230 Park Avenue, Suite 1540, New York, N.Y. 10169
Tel: +1 (212) 661-7566
[email protected]

About OET

OET is a leading international tanker company providing seaborne transportation of crude oil and refined products. The Company was incorporated on April 30, 2018 under the laws of the Republic of the Marshall Islands and is listed on Oslo Børs under the symbol OET and the New York Stock Exchange under the symbol ECO. The sailing fleet consists of six modern scrubber-fitted Suezmax tankers and eight modern scrubber-fitted VLCC tankers.

Forward-Looking Statements

This communication contains “forward-looking statements”, including as defined under U.S. federal securities laws. Forward-looking statements provide the Company’s current expectations or forecasts of future events. Forward-looking statements include statements about the Company’s expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts or that are not present facts or conditions. Words or phrases such as “anticipate,” “believe,” “continue,” “estimate,” “expect,” “hope,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will” or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. The Company’s actual results could differ materially from those anticipated in forward-looking statements for many reasons, including as described in the Company’s filings with the Commission. Accordingly, you should not unduly rely on these forward-looking statements, which speak only as of the date of this communication. Factors that could cause actual results to differ materially include, but are not limited to, the Company’s operating or financial results; the Company’s liquidity, including its ability to service its indebtedness; competitive factors in the market in which the Company operates; shipping industry trends, including charter rates, vessel values and factors affecting vessel supply and demand; future, pending or recent acquisitions and dispositions, business strategy, areas of possible expansion or contraction, and expected capital spending or operating expenses; risks associated with operations; broader market impacts arising from war (or threatened war) or international hostilities; risks associated with pandemics, including effects on demand for oil and other products transported by tankers and the transportation thereof; and other factors listed from time to time in the Company’s filings with the Commission. Except to the extent required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. You should, however, review the factors and risks the Company describes in the reports it files and furnishes from time to time with the Commission, which can be obtained free of charge on the Commission’s website at www.sec.gov.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



Middlesex Water Company Declares Quarterly Cash Dividend

ISELIN, N.J., April 25, 2025 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX) announced today that its Board of Directors has declared a quarterly cash dividend of $0.34 per share on its common stock, payable June 2, 2025 to shareholders of record as of May 15, 2025.

About Middlesex Water Company
Middlesex Water Company (NASDAQ: MSEX) is one of the nation’s premier investor-owned water and wastewater utilities. Established in 1897, Middlesex is a trusted provider of life-sustaining services to more than half a million people in New Jersey and Delaware. The company focuses on employee engagement, operational excellence, superior customer experience, investment in infrastructure, and selective and sustainable growth to deliver value to our customers, investors, and the communities we serve.

Media Contact:
Brian Hague, Vice President of Communications & Corporate Affairs
[email protected]
(732) 638-7549

Investor Relations Contact:
Jennifer Ketschke, Director, Treasury and Investor Relations
[email protected]
(732) 638-7523



Arbor Realty Trust Schedules First Quarter 2025 Earnings Conference Call

UNIONDALE, N.Y., April 25, 2025 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced that it is scheduled to release first quarter 2025 financial results before the market opens on Friday, May 2, 2025. The Company will host a conference call to review the results at 10:00 a.m. Eastern Time on May 2, 2025.

A live webcast and replay of the conference call will be available at www.arbor.com in the investor relations section of the Company’s website. Those without web access should access the call telephonically at least ten minutes prior to the conference call. The dial-in numbers are (800) 579-2543 for domestic callers and (785) 424-1789 for international callers. Please use participant passcode ABRQ125 when prompted by the operator.

A telephonic replay of the call will be available until May 9, 2025. The replay dial-in numbers are (800) 934-2127 for domestic callers and (402) 220-1139 for international callers.


About Arbor Realty Trust, Inc.

Arbor Realty Trust, Inc. (NYSE: ABR) is a nationwide real estate investment trust and direct lender, providing loan origination and servicing for multifamily, single-family rental (SFR) portfolios, and other diverse commercial real estate assets. Headquartered in New York, Arbor manages a multibillion-dollar servicing portfolio, specializing in government-sponsored enterprise products. Arbor is a leading Fannie Mae DUS® lender, Freddie Mac Optigo® Seller/Servicer, and an approved FHA Multifamily Accelerated Processing (MAP) lender. Arbor’s product platform also includes bridge, CMBS, mezzanine, and preferred equity loans. Rated by Standard and Poor’s and Fitch Ratings, Arbor is committed to building on its reputation for service, quality, and customized solutions with an unparalleled dedication to providing our clients excellence over the entire life of a loan.

Contact:

Arbor Realty Trust, Inc.
Investor Relations
516-506-4200
[email protected]
 



EAGLE FINANCIAL SERVICES, INC. ANNOUNCES 2025 FIRST QUARTER FINANCIAL RESULTS AND QUARTERLY DIVIDEND

PR Newswire


BERRYVILLE, Va.
, April 25, 2025 /PRNewswire/ — Eagle Financial Services, Inc. (NASDAQ: EFSI) (the “Company”), the holding company for Bank of Clarke, whose divisions include Bank of Clarke Wealth Management, announced its first quarter 2025 results. On April 23, 2025, the Board of Directors announced a quarterly common stock cash dividend of $0.31 per common share, payable on May 16, 2025, to shareholders of record on May 5, 2025. The following table presents selected financial performance highlights for the periods indicated:


Three Months Ended


March 31,


December 31,


March 31,


2025


2024


2024


(in thousands)


As adjusted (1)


As adjusted (1)


Consolidated net income (loss)

$

(6,974)

$

2,842

$

6,186

$

3,125

$

2,548


Consolidated noninterest income (loss)

$

(8,554)

$

3,871

$

8,521

$

4,647

$

3,480


Earnings (loss) per share – basic and diluted

$

(1.53)

$

0.62

$

1.74

$

0.88

$

0.72


Annualized return on average equity

(20.75)

%

8.46

%

21.10

%

10.66

%

9.53

%


Annualized return on average assets

(1.48)

%

0.59

%

1.32

%

0.67

%

0.58

%


Net interest margin

2.98

%

2.98

%

3.03

%

3.03

%

3.00

%

(1) Non-GAAP financial measure – Excluding the tax effected impact of the loss on sale of securities for the three months ended March 31, 2025 and the gain on sale of the Old Town Center (“OTC”) building as a result of the executed sale-leaseback transaction for the three months ended December 31, 2024. See the “Reconciliation of GAAP to Non-GAAP Performance Highlights” table for a reconciliation of these measures to comparable measures calculated in accordance with GAAP.

 

On February 13, 2025, the Company completed an underwritten public offering of 1,796,875 shares of its common stock at a public offering price of $32.00 per share. The net proceeds from the offering were $53.5 million. The Company also executed balance sheet repositioning transactions to support continued organic growth and capital generation.  The Company sold available for sale debt securities with an amortized cost balance of $99.2 million (fair value of $86.8 million) and a weighted average yield of 1.72% and reinvested $66.0 million into purchases of available for sale debt securities with a weighted average yield of 4.72%.  The sale of debt securities resulted in a net pre-tax realized loss of $12.4 million (after-tax of $9.8 million) that was recognized in the first quarter of 2025.

Additional key highlights for the first quarter of 2025 are as follows:

  • Core deposit growth of $42.2 million or 3.3% during the quarter.
  • FHLB borrowings decreased by $55.0 million during the quarter to $65.0 million.
  • Wealth Management fee income increased by $301 thousand or 21.8% during the quarter to $1.7 million.
  • Sales of $33.7 million and $2.0 million in mortgage and SBA loans, respectively, with a gain on sale of $429 thousand recognized during the quarter.

Brandon Lorey, President and CEO, stated, “The first quarter of 2025 has been a period of transformation for Eagle Financial Services and the Bank of Clarke. With the completion of an over-subscribed capital raise, an uplist to the NASDAQ stock exchange, and a successful repositioning of our securities portfolio, the organization is now optimally positioned to deliver significantly improved shareholder value in the coming quarters and years. We continued to experience strong low-cost core deposit growth of $42.2 million in the quarter, allowing further reduction in borrowings and strengthening our loan-to-deposit ratio. I am also thrilled to report that the Board has selected Mrs. Cary Nelson as its new Chair. Mrs. Nelson will be superseding Mr. Tom Gilpin, who announced his retirement from the Board in December of last year. Mrs. Nelson has served on the Board since 2018 and will officially begin her role as Chair after the Company’s annual meeting in May 2025. I would like to extend my gratitude to the entire team at EFSI and the Bank for their continued commitment to our shareholders, communities, and customers.”

Income Statement Review

Total net income (loss) for the quarters ended March 31, 2025 and December 31, 2024 was ($7.0 million) and $6.2 million, respectively. Total net (loss) for the quarter ended March 31, 2025 included a loss on sale of securities of $12.4 million related to an executed balance sheet repositioning. Total net income for the quarter ended December 31, 2024 included a gain on the sale of the OTC building as a part of a sale leaseback transaction. Net income, as adjusted to excluded the one-time effects of these significant transactions, for the quarter ended March 31, 2025 was $2.8 million reflecting a decrease of 9.0% from the quarter ended December 31, 2024 and an increase of 11.5% from the quarter ended March 31, 2024. Net income, as adjusted, was $3.1 million for the three-month period ended December 31, 2024 and $2.5 million for the quarter ended March 31, 2024. This is a non-GAAP financial measure. Please refer to the “Reconciliation of GAAP to Non-GAAP Performance Highlights” table for additional information. table for additional information. The decrease from the quarter ended December 31, 2024 was due to an increased provision for credit losses and lower noninterest income, partially offset by a decrease in salaries and employee benefits expense during the quarter ended March 31, 2025. The increase from the quarter ended March 31, 2024 was due  largely to an increase in net interest income and partially offset by the increased provision for credit losses during the quarter ended March 31, 2025. These changes are discussed below in greater detail.

Total loan interest income was $20.0 million and $21.1 million for the quarters ended March 31, 2025 and December 31, 2024 respectively. Total loan interest income was $20.0 million for the quarter ended March 31, 2024. Total loan interest income decreased $1.1 million or 5.6% from the quarter ended December 31, 2024 to the quarter ended March 31, 2025. The decrease in loan interest income for the first quarter of 2025 compared to the fourth quarter of 2024 is due to the decreases in lower average loan balance and loan yield along with a higher volume of mortgage loans sales and several loan relationships being placed on nonaccrual status. Average loans decreased from $1.48 billion for the quarter ended December 31, 2024 to $1.46 billion for the quarter ended March 31, 2025. The tax equivalent yield on average loans for the quarter ended March 31, 2025 was 5.57%, a decrease of 13 basis points from the 5.70% average yield for the quarter ended December 31, 2024. Early during the first quarter, ahead of its public offering, the Company sold an additional pool of mortgage loans at par in order to bolster on-balance sheet liquidity. This pool had a total balance of $18.8 million with a weighted average yield of 6.58%. In addition, $202 thousand in accrued interest income was reversed when one loan relationship totaling $12.5 million with a weighted average yield of 8.73% was placed in nonaccrual status.

Interest and dividend income from the investment portfolio was $848 thousand for the quarter ended March 31, 2025 compared to $879 thousand for the quarter ended December 31, 2024. Interest and dividend income from the investment portfolio was $919 thousand for the quarter ended March 31, 2024. The tax equivalent yield on average investments for the quarter ended March 31, 2025 was 2.93%, up 36 basis points from 2.57% for the quarter ended December 31, 2024 and up 35 basis points from 2.58% for the quarter ended March 31, 2024. The increase in yield was due largely in part to lower yielding investments sold during the first quarter of 2025 being replaced with higher yielding securities being purchased. During the quarter ended March 31, 2025, $99.2 million in securities were sold with a weighted average yield of 1.72%. During the same quarter, $76.0 million in securities were purchased.  Of the $76.0 million in securities purchased, $66.0 million were purchased as a part of the executed balance sheet repositioning with a weighted average yield of 4.72%. 

Total interest expense was $10.2 million and $10.5 million for the three months ended March 31, 2025 and December 31, 2024, respectively and $9.5 million for three months ended March 31, 2024. The increase in interest expense between the quarter ended March 31, 2025 and the quarter ended March 31, 2024 was due to the growth in interest-bearing deposit accounts year over year. The average balance of interest-bearing liabilities increased $90.9 million from the quarter ended March 31, 2024 to the same period in 2025 while the average cost of interest-bearing liabilities increased only two basis points when comparing the same period. The decrease in interest expense between the quarter ended March 31, 2025 and the quarter ended December 31, 2024 was due primarily to the payoff of one Federal Home Loan Bank advance totaling $55.0 million in February 2025.

Net interest income for the quarter ended March 31, 2025 was $13.3 million reflecting a decrease of 1.2% from the quarter ended December 31, 2024 and an increase of 7.4% from the quarter ended March 31, 2024. Net interest income was $13.5 million and $12.4 million, respectively, for the quarters ended December 31, 2024 and March 31, 2024.

The net interest margin was 2.98% for the quarter ended March 31, 2025. For the quarters ended December 31, 2024 and March 31, 2024, the net interest margin was 3.03% and 3.00%, respectively. The decrease in the net interest margin from December 31, 2024 and March 31, 2024 is mainly due to the $18.8 million pool of mortgage loans sold during the first quarter of 2025 with a weighted average yield of 6.58%. In addition, $202 thousand in accrued interest income was reversed when one loan relationship totaling $12.5 million with a weighted average yield of 8.73% was placed in nonaccrual status. The Company’s net interest margin is not a measurement under accounting principles generally accepted in the United States, but it is a common measure used by the financial services industry to determine how profitably earning assets are funded. The Company’s net interest margin is calculated by dividing tax equivalent net interest income by total average earning assets. Tax equivalent net interest income is calculated by grossing up interest income for the amounts that are non-taxable (i.e., municipal income) then subtracting interest expense. The tax rate utilized is 21%. This is a non-GAAP financial measure. Please refer to the “Reconciliation of Tax-Equivalent Net Interest Income” table for additional information.

Total noninterest income (loss) was $(8.6 million) and $8.5 million for the quarters ended March 31, 2025 and December 31, 2024 respectively. Total noninterest income was $3.5 million for the quarter ended March 31, 2024. As discussed above, the quarters ended March 31, 2025 and December 31, 2024 each included a significant transaction. Noninterest income, as adjusted to exclude the one-time effects of these significant transactions, was $3.9 million for the quarter ended March 31, 2025, which represented a decrease of $774 thousand or 16.7% from $4.6 million for the three months ended December 31, 2024. This is a non-GAAP financial measure. Please refer to the “Reconciliation of GAAP to Non-GAAP Performance Highlights” table for additional information. Noninterest income for the quarter ended March 31, 2024 was $3.5 million. The decrease in total noninterest income when comparing the first quarter of 2025 and the fourth quarter of 2024 is due to reduced small business investment company (“SBIC”) income along with lower gains on sale of loans held for sale. The timing of SBIC income varies and is not received consistently each quarter. Gains on loans held for sale were lower during the first quarter of 2025 due to less sales activity in the SBA portfolio. The Company sold two SBA loans totaling $2.0 million for a gain of $125 thousand during the first quarter of 2025, as compared to the sale of six SBA loans totaling $7.4 million for a gain of $554 thousand during the fourth quarter of 2024.

Noninterest expense decreased $966 thousand, or 7.1%, to $12.6 million for the quarter ended March 31, 2025 from $13.6 million for the quarter ended December 31, 2024. Noninterest expense was $12.4 million for the quarter ended March 31, 2024, representing an increase of $212 thousand or 1.7% when comparing the quarter ended March 31, 2025 to the quarter ended March 31, 2024. A $794 thousand or 10.0% decrease in salaries and benefits expenses was noted between March 31, 2025 and December 31, 2024. This is mainly due to lower incentive accruals for the first quarter of 2025 due to thresholds for several incentive plans having not been met.

Asset Quality and Provision for Credit Losses

Nonperforming assets consist of nonaccrual loans, loans 90 days or more past due and still accruing, other real estate owned (foreclosed properties), and repossessed assets. Nonperforming assets increased from $3.0 million or 0.16% of total assets at December 31, 2024 to $16.4 million or 0.86% of total assets at March 31, 2025. Nonperforming assets were $5.0 million or 0.28% of total assets at March 31, 2024. Nonperforming assets increased as of March 31, 2025 in comparison to December 31, 2024 and March 31, 2024 mainly due to two large relationships being placed in nonaccrual status during the first quarter of 2025.  These two relationships had a total balance of $13.7 million as of  March 31, 2025. The majority of all nonaccrual loans are secured by real estate and management evaluates the financial condition of these borrowers and the value of any collateral on these loans. The results of these evaluations are used to estimate the amount of losses which may be realized on the disposition of these nonaccrual loans. Specific reserves on nonaccrual loans totaled $152 thousand, $248 thousand and zero as of March 31, 2025, December 31, 2024 and March 31, 2024, respectively.

The Company realized $891 thousand in net charge-offs for the quarter ended March 31, 2025 compared to $486 thousand for the three months ended December 31, 2024. During the three months ended March 31, 2024, $520 thousand in net charge-offs were recognized. The majority of the charge-offs recognized during the first quarter of 2025 were related to one nonaccrual relationship being written down by $971 thousand to fair market value. The majority of the charge-offs recognized during the fourth quarter of 2024 were related to two loans in the marine portfolio and does not reflect a systemic performance issue within that portfolio.

The ratio of allowance for credit losses to total loans was 1.05% and 1.02% at March 31, 2025 and December 31, 2024, respectively. The ratio of allowance for credit losses to total loans was 1.00% at March 31, 2024. The amount of provision for credit losses on loans reflects the results of the Bank’s analysis used to determine the adequacy of the allowance for credit losses. The Company recorded $1.1 million in provision for credit loss on loans for the quarter ended March 31, 2025. The Company recognized provision for credit losses on loans of $210 thousand and $475 thousand for the quarters ended December 31, 2024 and March 31, 2024, respectively. The provision for the quarter ended March 31, 2025 was mainly due to the larger net charge-offs during the quarter. The provision for the quarters ended December 31, 2024 and March 31, 2024 was mainly to replenish the allowance for credit losses due to net charge-offs and moderate loan growth. Management’s judgment in determining the level of the allowance is based on evaluations of the collectability of loans while taking into consideration such factors as trends in delinquencies and charge-offs, changes in the nature and volume of the loan portfolio, current economic conditions that may affect a borrower’s ability to repay and the value of collateral, overall portfolio quality and review of specific potential losses. The Company is committed to maintaining an allowance at a level that adequately reflects expected credit losses over the life of the loan portfolio.

Balance Sheet

Total consolidated assets of the Company at March 31, 2025 was $1.90 billion, which represented an increase of $38.3 million or 2.05% from total assets of $1.87 billion at December 31, 2024. At March 31, 2024, total consolidated assets were $1.78 billion. Total assets increased during the first quarter of 2025 due mainly to $53.5 million in net proceeds received from the Company’s public offering of common shares completed during the first quarter of 2025. See the Capital and Dividends section for additional information. 

Total net loans decreased $15.0 million from $1.45 billion at December 31, 2024 to $1.44 billion at March 31, 2025 driven largely by marine amortization of $6.6 million and residential mortgage decrease of $16.9 million. During the quarter ended March 31, 2025, through the normal course of business, $14.9 million in residential mortgage loans were sold on the secondary market. These loan sales resulted in net gains of $299 thousand. In addition, early during the first quarter, ahead of its public offering, the Company sold an additional pool of mortgage loans previously held for investment at par in order to bolster on-balance sheet liquidity. This pool had a total balance of $18.8 million. During the quarter ended December 31, 2024, $18.6 million in mortgage loans were sold on the secondary market. These loan sales resulted in net gains of $308 thousand.

Total deposits increased to $1.61 billion as of March 31, 2025 when compared to December 31, 2024 deposits of $1.58 billion. At March 31, 2024 total deposits were $1.47 billion. During the first quarter of 2025, total deposits increased $38.6 million. The majority of this increase was due to savings and interest bearing demand deposit balances increasing by $18.3 million and noninterest bearing demand deposits increasing $15.2 million. Year over year deposits increased $139.8 million and the majority of the growth was in time deposits. Core deposit growth for the quarter and twelve months ended March 31, 2025 and was $42.2 million and $80.7 million, respectively. Core deposits consist of checking accounts, NOW accounts, money market accounts, regular savings accounts and time deposits less than $250 thousand.

Liquidity

The objective of the Company’s liquidity management is to ensure the continuous availability of funds to satisfy the credit needs of our customers and the demands of our depositors, creditors and investors. Uninsured deposits represent an estimate of amounts above the Federal Deposit Insurance Corporation (FDIC) insurance coverage limit of $250,000. As of March 31, 2025, the Company’s uninsured deposits were approximately $189.8 million, or 11.8% of total deposits.

The Company’s liquid assets, which include cash and due from banks, interest-bearing deposits at other banks, loans with a maturity less than one year and non-pledged securities available for sale, were $412.0 million and borrowing availability was $466.4 million as of March 31, 2025, which in total exceed uninsured deposits, excluding intercompany cash holdings and secured municipal deposits, by $688.6 million.  Liquid assets have increased by $76.2 million during the first quarter mainly due to a $71.8 million increase in cash and cash equivalent balance. In addition to deposits, the Company utilizes short-term and long-term borrowings as sources of funds. Short-term borrowings from the Federal Reserve Bank and the Federal Home loan Bank of Atlanta (FHLB) as well as federal funds purchased from Community Bankers Bank may be used to fund the Company’s day-to-day operations. Long-term borrowings include FHLB advances as well as subordinated debt. Total outstanding borrowings decreased to $94.5 million at March 31, 2025 from $184.8 million at March 31, 2024. Borrowings decreased $55.0 million from $149.5 million at December 31, 2024. These decreases were primarily due to the capital raise, strong deposit growth and higher levels of loan sales enabling the payoff of borrowings. 

Additional sources of liquidity available to the Company include cash flows from operations, loan payments and payoffs, deposit growth, maturities, calls and sales of securities and the issuance of brokered certificates of deposit.  

Capital and Dividends

On April 23, 2025, the Board of Directors announced a quarterly common stock cash dividend of $0.31 per common share, payable on May 16, 2025, to shareholders of record on May 5, 2025. The Board of Directors of the Company continually reviews the amount of cash dividends per share and the resulting dividend payout ratio in light of changes in economic conditions, current and future capital requirements, and expected future earnings.  

Total consolidated equity increased $68.8 million at March 31, 2025 compared to March 31, 2024 and increased $57.5 million compared to December 31, 2024. During the first quarter of 2025, the Company completed a public offering. A total of 1,796,875 shares were issued with net proceeds of $53.5 million.

The Company’s securities available for sale are fixed income debt securities and their unrealized loss position is a result of increased market interest rates since they were purchased. The Company expects to recover its investments in debt securities through scheduled payments of principal and interest. The accumulated other comprehensive loss related to the Company’s securities available for sale decreased to $6.6 million at March 31, 2025 compared to $18.6 million at December 31, 2024. As a part of a balance sheet repositioning as discussed above, the Bank sold available for sale debt securities with an amortized cost balance of $99.2 million (fair value of $86.8 million) and a weighted average yield of 1.72% and reinvested $66.0 million into purchases of available for sale debt securities with a weighted average yield of 4.70%. The sale of debt securities resulted in a net pre-tax realized loss of $12.4 million (after-tax of $9.8 million) that was recognized in the first quarter of 2025.

As of March 31, 2025, the most recent notification from the FDIC categorized the Bank of Clarke as well capitalized under the regulatory framework for prompt corrective action. To be categorized as well capitalized under regulations applicable at March 31, 2025, Bank of Clarke was required to maintain minimum total risk-based, Tier 1 risk-based, CET1 risk-based and Tier 1 leverage ratios. In addition to the regulatory risk-based capital requirements, Bank of Clarke must maintain a capital conservation buffer of additional capital of 2.5 percent of risk-weighted assets as required by the Basel III capital rules.  The Bank of Clarke exceeded these ratios at March 31, 2025.

Explanation of Non-GAAP Financial Measures  

This release contains financial information determined by methods other than in accordance with GAAP. Management believes that the supplemental Non-GAAP information provides a better comparison of period-to-period operating performance and the impact of non-recurring expenses on the Bank’s results. Additionally, the Company believes this information is utilized by regulators and market analysts to evaluate a company’s results and financial condition and therefore, such information is useful to investors. These disclosures should not be viewed as a substitute for or more important than financial results in accordance with GAAP, nor are they necessarily comparable to non-GAAP performance measures which may be presented by other companies.

Cautionary Note Regarding Forward-Looking Statements

Certain information contained in this discussion may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to the Company’s future operations and are generally identified by phrases such as “the Company expects,” “the Company believes” or words of similar import. Although the Company believes that its expectations with respect to the forward-looking statements are based upon reliable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results, performance or achievements of the Company will not differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.

Factors that could have a material adverse effect on the operations and future prospects of the Company include, but are not limited to: changes in interest rates and general economic conditions; the legislative and regulatory climate; monetary and fiscal policies of the U.S. Government, including policies of the U.S. Treasury and Federal Reserve; the quality or composition of the Company’s loan or investment portfolios; demand for loan products; deposit flows; competition; demand for financial services in the Company’s market area; acquisitions and dispositions; the Company’s ability to keep pace with new technologies; a failure in or breach of the Company’s operational or security systems or infrastructure, or those of third-party vendors or other service providers, including as a result of cyberattacks; the Company’s capital and liquidity; changes in tax and accounting rules, principles, policies and guidelines; and other factors included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the Securities and Exchange Commission.


EAGLE FINANCIAL SERVICES, INC.


KEY STATISTICS (unaudited)


For the Three Months Ended


1Q25


4Q24


3Q24


2Q24


1Q24

Net income (loss) (dollars in thousands)

$

(6,974)

$

6,186

$

3,424

$

3,185

$

2,548

Earnings (loss) per share, basic

$

(1.53)

$

1.74

$

0.97

$

0.89

$

0.72

Earnings (loss) per share, diluted

$

(1.53)

$

1.74

$

0.97

$

0.89

$

0.72

Return on average total assets (annualized)

(1.48)

%

1.32

%

0.75

%

0.72

%

0.58

%

Return on average total equity (annualized)

(20.75)

%

21.10

%

11.99

%

11.76

%

9.53

%

Dividend payout ratio

N/M

17.82

%

30.93

%

33.71

%

41.67

%

Fee revenue as a percent of total revenue (1)

N/M

12.79

%

17.11

%

17.57

%

18.11

%

Net interest margin(2)

2.98

%

3.03

%

3.03

%

2.92

%

3.00

%

Yield on average earning assets (annualized)

5.25

%

5.39

%

5.45

%

5.22

%

5.28

%

Rate on average interest-bearing liabilities (annualized)

3.12

%

3.18

%

3.27

%

3.14

%

3.10

%

Net interest spread

2.13

%

2.21

%

2.18

%

2.08

%

2.18

%

Non-interest income (loss) to average assets

(1.82)

%

1.81

%

1.15

%

0.97

%

0.78

%

Non-interest expense to average assets

2.68

%

2.88

%

2.81

%

2.82

%

2.80

%

Efficiency ratio(3)

72.20

%

74.58

%

71.34

%

77.00

%

77.73

%

N/M – Not meaningful

(1) Fee revenue as a percentage of total revenue is calculated by dividing the sum of wealth management fees, service charges on deposit accounts and other service charges and fees by the sum of net interest income and non-interest income. 

(2) Non-GAAP financial measure – The annualized net interest margin is calculated by dividing tax equivalent net interest income by total average earning assets. Tax equivalent interest income is calculated by grossing up interest income for the amounts that are non-taxable (i.e., municipal income) then subtracting interest expense. The rate utilized is 21%.  Please refer to the “Reconciliation of Tax-Equivalent Net Interest Income” table for the quarterly tax equivalent net interest income and the reconciliation of net interest income to tax equivalent net interest income. The Company’s net interest margin is a common measure used by the financial service industry to determine how profitable earning assets are funded. Because the Company earns a fair amount of nontaxable interest income due to the mix of securities in its investment security portfolio, net interest income for the ratio is calculated on a tax equivalent basis as described above.

(3) Non-GAAP financial measure – The efficiency ratio is not a measurement under accounting principles generally accepted in the United States. It is calculated by dividing non-interest expense by the sum of tax equivalent net interest income and non-interest income excluding gains and losses on the investment portfolio, the gain on the sale of OTC and sales of repossessed assets. The tax rate utilized is 21%. See the table below for the quarterly tax equivalent net interest income and a reconciliation of net interest income to tax equivalent net interest income. The Company calculates this ratio in order to evaluate its overhead structure or how effectively it is operating. An increase in the ratio from period to period indicates the Company is losing a larger percentage of its income to expenses. The Company believes that the efficiency ratio is a reasonable measure of profitability. Please refer to the “Reconciliation of GAAP to Non-GAAP Performance Highlights” table for additional information.

 


EAGLE FINANCIAL SERVICES, INC.


SELECTED FINANCIAL DATA BY QUARTER (unaudited)

 


(Dollars in thousands, except per share data)


1Q25


4Q24


3Q24


2Q24


1Q24


BALANCE SHEET RATIOS

Loans to deposits

89.99

%

93.14

%

95.95

%

97.34

%

97.63

%

Average interest-earning assets to average-interest bearing liabilities

137.78

%

134.93

%

135.10

%

136.75

%

135.92

%


PER SHARE DATA

Dividends

$

0.31

$

0.31

$

0.30

$

0.30

$

0.30

Book value

32.81

33.52

33.20

31.24

30.28


SHARE PRICE DATA

Closing price

$

32.79

$

36.40

$

32.40

$

32.99

$

29.85

Diluted earnings multiple(1)

N/M

5.23

8.35

9.27

10.36

Book value multiple(2)

1.00

1.09

0.98

1.06

0.99


COMMON STOCK DATA

Outstanding shares at end of period

5,378,653

3,549,581

3,549,581

3,556,844

3,557,229

Weighted average shares outstanding

4,572,297

3,549,581

3,552,026

3,556,935

3,557,203

Weighted average shares outstanding, diluted

4,572,297

3,549,581

3,552,026

3,556,935

3,557,203


CREDIT QUALITY

Net charge-offs (recoveries) to average loans

0.06

%

0.03

%

0.08

%

(0.02)

%

0.04

%

Total non-performing loans to total loans

1.13

%

0.17

%

0.16

%

0.20

%

0.32

%

Total non-performing assets to total assets

0.86

%

0.16

%

0.13

%

0.18

%

0.28

%

Non-accrual loans to:

Total loans

1.11

%

0.14

%

0.16

%

0.19

%

0.29

%

Total assets

0.85

%

0.11

%

0.12

%

0.15

%

0.23

%

Allowance for credit losses to:

Total loans

1.05

%

1.02

%

1.03

%

1.04

%

1.00

%

Non-performing assets

93.45

%

506.30

%

605.82

%

458.72

%

290.00

%

Non-accrual loans

94.79

%

725.24

%

652.86

%

555.46

%

347.64

%


NON-PERFORMING ASSETS:

Loans delinquent over 90 days

$

230

$

382

$

83

$

167

$

411

Non-accrual loans

16,122

2,072

2,344

2,703

4,156

Other real estate owned and repossessed assets

514

99

403

415


NET LOAN CHARGE-OFFS (RECOVERIES):

Loans charged off

$

1,076

$

585

$

1,382

$

172

$

705

(Recoveries)

(185)

(99)

(145)

(424)

(185)

Net charge-offs (recoveries)

891

486

1,237

(252)

520


PROVISION FOR CREDIT LOSSES ON LOANS

$

1,146

$

210

$

1,525

$

315

$

475


ALLOWANCE FOR CREDIT LOSSES

$

15,282

$

15,027

$

15,303

$

15,014

$

14,448

N/M – Not meaningful

(1) The diluted earnings multiple (or price earnings ratio) is calculated by dividing the period’s closing market price per share by total equity per weighted average shares outstanding, diluted for the period. The diluted earnings multiple is a measure of how much an investor may be willing to pay for $1.00 of the Company’s earnings.

(2) The book value multiple (or price to book ratio) is calculated by dividing the period’s closing market price per share by the period’s book value per share. The book value multiple is a measure used to compare the Company’s market value per share to its book value per share.

 


EAGLE FINANCIAL SERVICES, INC.


CONSOLIDATED BALANCE SHEETS


(dollars in thousands)


Unaudited
03/31/2025


*
12/31/2024


Unaudited
09/30/2024


Unaudited
06/30/2024


Unaudited
03/31/2024


Assets

Cash and due from banks

$

16,527

$

13,129

$

15,418

$

15,202

$

12,887

Interest-bearing deposits with other institutions

187,018

162,595

162,187

45,977

55,393

Federal funds sold

61,401

17,435

3,586

62,476

59,353

Securities available for sale, at fair value

114,844

128,887

140,018

138,269

141,106

Loans held for sale

3,173

2,660

3,657

3,058

1,593

Loans, net of allowance for credit losses

1,436,982

1,452,022

1,468,025

1,433,920

1,424,604

Bank premises and equipment, net

14,625

14,339

18,101

18,114

17,954

Bank owned life insurance

30,894

30,621

30,361

30,103

29,843

Other assets

39,013

44,527

40,348

43,286

40,168

Total assets

$

1,904,477

$

1,866,215

$

1,881,701

$

1,790,405

$

1,782,901


Liabilities and Shareholders’ Equity


Liabilities

Deposits:

Noninterest bearing demand deposits

$

421,342

$

406,180

$

413,615

$

415,017

$

424,869

Savings and interest bearing demand deposits

697,679

679,330

655,601

647,358

666,730

Time deposits

494,770

489,646

476,720

426,209

382,343

Total deposits

$

1,613,791

$

1,575,156

$

1,545,936

$

1,488,584

$

1,473,942

Federal funds purchased

244

302

347

Federal Home Loan Bank advances, short-term

25,000

10,000

Federal Home Loan Bank advances, long-term

40,000

120,000

170,000

145,000

145,000

Subordinated debt, net

29,529

29,512

29,495

29,478

29,461

Other liabilities

19,682

22,560

18,182

15,926

16,446

Total liabilities

$

1,728,002

$

1,747,228

$

1,763,857

$

1,679,290

$

1,675,196

Commitments and contingent liabilities


Shareholders’ Equity

Preferred stock, $10 par value

Common stock, $2.50 par value

13,252

8,714

8,714

8,707

8,705

Surplus

63,922

14,901

14,633

14,604

14,368

Retained earnings

105,928

114,012

108,927

106,567

104,449

Accumulated other comprehensive (loss)

(6,627)

(18,640)

(14,430)

(18,763)

(19,817)

Total shareholders’ equity

$

176,475

$

118,987

$

117,844

$

111,115

$

107,705

Total liabilities and shareholders’ equity

$

1,904,477

$

1,866,215

$

1,881,701

$

1,790,405

$

1,782,901

* Derived from audited consolidated financial statements.

 


EAGLE FINANCIAL SERVICES, INC.


LOAN DATA (unaudited)


(dollars in thousands)


3/31/2025


12/31/2024


9/30/2024


6/30/2024


3/31/2024

Mortgage real estate loans:

   Construction & Secured by Farmland

$

98,660

$

95,200

$

97,170

$

81,609

$

82,692

   HELOCs

50,543

50,646

50,452

46,697

46,329

   Residential First Lien – Investment

108,519

105,910

106,323

112,790

113,813

   Residential First Lien – Owner Occupied

174,822

194,065

198,570

187,807

181,323

   Residential Junior Liens

10,983

11,184

11,956

12,387

12,690

   Commercial – Owner Occupied

268,990

272,236

273,249

257,675

254,744

   Commercial –  Non-Owner Occupied & Multifamily

374,471

367,680

357,351

352,892

344,192

Commercial and industrial loans:

   BHG loans

3,248

3,566

3,810

4,284

4,740

   SBA PPP loans

22

28

34

39

45

   Other commercial and industrial loans

109,658

106,749

107,320

102,345

95,327

Marine loans

203,455

210,095

225,902

236,890

247,042

Triad Loans

22,528

22,894

23,616

24,579

25,335

Consumer loans

7,898

8,123

8,447

9,497

9,194

Overdrafts

208

309

215

257

1,559

Other loans

11,822

11,911

11,932

11,951

12,466

Total loans

$

1,445,827

$

1,460,596

$

1,476,347

$

1,441,699

$

1,431,491

Net deferred loan costs and premiums

6,437

6,453

6,981

7,235

7,561

Allowance for credit losses

(15,282)

(15,027)

(15,303)

(15,014)

(14,448)

Net loans

$

1,436,982

$

1,452,022

$

1,468,025

$

1,433,920

$

1,424,604

 


EAGLE FINANCIAL SERVICES, INC.


CONSOLIDATED STATEMENTS OF INCOME (LOSS) (unaudited)


(dollars in thousands, except per share data)


3/31/2025


12/31/2024


9/30/2024


6/30/2024


3/31/2024


Interest and Dividend Income

Interest and fees on loans

$

19,971

$

21,148

$

21,143

$

19,525

$

19,963

Interest on federal funds sold

39

5

11

68

39

Interest and dividends on securities available for sale:

Taxable interest income

695

713

712

739

758

Interest income exempt from federal income taxes

3

4

4

3

5

Dividends

150

162

157

155

156

Interest on deposits in banks

2,644

1,962

1,659

1,248

982

Total interest and dividend income

$

23,502

$

23,994

$

23,686

$

21,738

$

21,903


Interest Expense

Interest on deposits

$

8,504

$

8,496

$

8,419

$

7,515

$

7,424

Interest on Federal Home Loan Bank advances

1,308

1,645

1,756

1,712

1,710

Interest on subordinated debt

354

354

354

355

354

Total interest expense

$

10,166

$

10,495

$

10,529

$

9,582

$

9,488

Net interest income

$

13,336

$

13,499

$

13,157

$

12,156

$

12,415


Provision For Credit Losses

1,233

351

1,544

181

475

Net interest income after provision for credit losses

$

12,103

$

13,148

$

11,613

$

11,975

$

11,940


Noninterest Income

Wealth management fees

$

1,681

$

1,380

$

1,515

$

1,273

$

1,456

Service charges on deposit accounts

492

508

518

456

454

Other service charges and fees

972

929

1,117

1,164

969

(Loss) gain on the sale and disposal of bank premises and equipment

(16)

3,874

(11)

(Loss) on the sale of AFS securities

(12,425)

Gain on sale of loans held for sale

429

861

627

492

161

Small business investment company income

20

475

496

259

127

Bank owned life insurance income

273

260

930

523

268

Other operating income

20

234

48

149

45

Total noninterest income (loss)

$

(8,554)

$

8,521

$

5,251

$

4,305

$

3,480


Noninterest Expenses

Salaries and employee benefits

$

7,179

$

7,973

$

7,548

$

7,353

$

7,185

Occupancy expenses

662

508

530

470

569

Equipment expenses

423

456

427

401

373

Advertising and marketing expenses

183

309

247

245

237

Stationery and supplies

42

54

35

32

24

ATM network fees

362

371

406

373

380

Loss of sale of reposessed assets

133

204

FDIC assessment

322

330

343

351

409

Computer software expense

282

388

226

221

233

Bank franchise tax

367

342

342

338

331

Professional fees

563

640

408

511

506

Data processing fees

550

616

679

558

565

Other operating expenses

1,521

1,568

1,495

1,657

1,565

Total noninterest expenses

$

12,589

$

13,555

$

12,890

$

12,510

$

12,377

Income (loss) before income taxes

$

(9,040)

$

8,114

$

3,974

$

3,770

$

3,043


Income Tax Expense (Benefit)

(2,066)

1,928

550

585

495

Net income (loss)

$

(6,974)

$

6,186

$

3,424

$

3,185

$

2,548


Earnings (Loss) Per Share

Net income (loss) per common share, basic

$

(1.53)

$

1.74

$

0.97

$

0.89

$

0.72

Net income (loss) per common share, diluted

$

(1.53)

$

1.74

$

0.97

$

0.89

$

0.72

 


EAGLE FINANCIAL SERVICES, INC.


Average Balances, Income and Expenses, Yields and Rates (unaudited)


(dollars in thousands)


Three Months Ended


March 31, 2025


December 31, 2024


March 31, 2024


Interest


Interest


Interest


Average


Income/


Average


Average


Income/


Average


Average


Income/


Average


Assets:


Balance


Expense


Rate


Balance


Expense


Rate


Balance


Expense


Rate

Securities:

Taxable

$

117,367

$

845

2.92

%

$

135,391

$

874

2.57

%

$

142,700

$

914

2.58

%

Tax-Exempt (1)

353

4

4.25

%

497

5

4.04

%

499

6

4.84

%

Total Securities

$

117,720

$

849

2.93

%

$

135,888

$

879

2.57

%

$

143,199

$

920

2.58

%

Loans:

Taxable

$

1,442,343

$

19,871

5.59

%

$

1,466,603

$

21,047

5.71

%

$

1,433,871

$

19,858

5.57

%

Non-accrual

3,959

%

2,355

%

5,618

%

Tax-Exempt (1)

10,130

127

5.07

%

10,153

129

5.04

%

10,706

133

4.99

%

Total Loans

$

1,456,432

$

19,998

5.57

%

$

1,479,111

$

21,176

5.70

%

$

1,450,195

$

19,991

5.54

%

Federal funds sold and interest-bearing
deposits in other banks

244,780

2,683

4.45

%

158,193

1,966

4.94

%

77,434

1,021

5.30

%

Total earning assets

$

1,818,932

$

23,530

5.25

%

$

1,773,192

$

24,021

5.39

%

$

1,670,828

$

21,932

5.28

%

Allowance for credit losses

(15,228)

(15,299)

(14,536)

Total non-earning assets

102,727

110,704

102,883

Total assets

$

1,906,431

$

1,868,597

$

1,759,175


Liabilities and Shareholders’ Equity:

Interest-bearing deposits:

NOW accounts

$

275,462

$

1,463

2.15

%

$

267,207

$

1,527

2.27

%

$

256,282

$

1,497

2.35

%

Money market accounts

274,142

1,512

2.24

%

268,846

1,557

2.30

%

263,755

1,413

2.15

%

Savings accounts

132,905

37

0.11

%

131,541

37

0.11

%

138,737

41

0.12

%

Time deposits:

$250,000 and more

186,048

2,115

4.61

%

171,735

1,976

4.58

%

143,294

1,701

4.77

%

Less than $250,000

311,499

3,377

4.40

%

303,617

3,399

4.45

%

251,853

2,772

4.43

%

Total interest-bearing deposits

$

1,180,056

$

8,504

2.92

%

$

1,142,946

$

8,496

2.96

%

$

1,053,921

$

7,424

2.83

%

Federal funds purchased

8

n/m

5

n/m

11

n/m

%

Federal Home Loan Bank advances

110,556

1,308

4.80

%

141,739

1,644

4.62

%

145,879

1,710

4.72

%

Subordinated debt

29,517

354

4.87

%

29,501

354

4.78

%

29,450

354

4.84

%

Total interest-bearing liabilities

$

1,320,137

$

10,166

3.12

%

$

1,314,191

$

10,494

3.18

%

$

1,229,261

$

9,488

3.10

%

Noninterest-bearing liabilities:

Demand deposits

426,947

418,505

405,166

Other Liabilities

23,071

19,245

17,268

Total liabilities

$

1,770,155

$

1,751,941

$

1,651,695

Shareholders’ equity

136,276

116,656

107,480

Total liabilities and shareholders’ equity

$

1,906,431

$

1,868,597

$

1,759,175

Net interest income

$

13,364

$

13,527

$

12,444

Net interest spread

2.13

%

2.21

%

2.18

%

Interest expense as a percent of average
earning assets

2.27

%

2.35

%

2.28

%

Net interest margin

2.98

%

3.03

%

3.00

%

(1) Non-GAAP financial measure – Income and yields are reported on tax-equivalent basis using a federal tax rate of 21%. Please refer to the “Reconciliation of Tax-Equivalent Net Interest Income” table for additional information.

 


EAGLE FINANCIAL SERVICES, INC.


Reconciliation of Tax-Equivalent Net Interest Income (unaudited)


(dollars in thousands)


Three Months Ended


3/31/2025


12/31/2024


9/30/2024


6/30/2024


3/31/2024


GAAP Financial Measurements:

Interest Income – Loans

$

19,971

$

21,148

$

21,143

$

19,525

$

19,963

Interest Income – Securities and Other Interest-Earnings Assets

3,531

2,846

2,543

2,213

1,940

Interest Expense – Deposits

8,504

8,496

8,419

7,515

7,424

Interest Expense – Other Borrowings

1,662

1,999

2,110

2,067

2,064


Total Net Interest Income

$

13,336

$

13,499

$

13,157

$

12,156

$

12,415


Non-GAAP Financial Measurements:

Add:  Tax Benefit on Tax-Exempt Interest Income – Loans

$

27

$

27

$

27

$

28

$

28

Add:  Tax Benefit on Tax-Exempt Interest Income – Securities

1

1

1

1

1


Total Tax Benefit on Tax-Exempt Interest Income

$

28

$

28

$

28

$

29

$

29


Tax-Equivalent Net Interest Income

$

13,364

$

13,527

$

13,185

$

12,185

$

12,444

 


EAGLE FINANCIAL SERVICES, INC.


Reconciliation of Efficiency Ratio (unaudited)


(dollars in thousands)


Three Months Ended


3/31/2025


12/31/2024


9/30/2024


6/30/2024


3/31/2024

Summary of Operating Results:

Noninterest expenses (GAAP)

$

12,589

$

13,555

$

12,890

$

12,510

$

12,377

Less: Loss on sale of repossessed assets

133

204

Adjusted noninterest expenses (non-GAAP)

$

12,456

$

13,555

$

12,686

$

12,510

$

12,377

Net interest income

13,336

13,499

13,157

12,156

12,415

Noninterest (loss) income (GAAP)

(8,554)

8,521

5,251

4,305

3,480

Less: (Loss) gain on the sale and disposal of premises and equipment

(16)

3,874

(11)

Less: (Loss) on the sale of securities

(12,425)

Less: Income from life insurance proceeds (1)

653

254

Adjusted noninterest income (non-GAAP)

$

3,887

$

4,647

$

4,598

$

4,062

$

3,480

Tax equivalent adjustment (2)

28

28

28

29

29

Total net interest income and noninterest income, adjusted (non-GAAP)

$

17,251

$

18,174

$

17,783

$

16,247

$

15,924

Efficiency ratio

72.20

%

74.58

%

71.34

%

77.00

%

77.73

%

(1) Included in the consolidated statements of income (loss) under the heading bank owned life insurance income. 

(2) Non-GAAP financial measure -Includes tax-equivalent adjustments on loans and securities using the federal statutory tax rate of 21%.

 


EAGLE FINANCIAL SERVICES, INC.


Reconciliation of GAAP to Non-GAAP Performance Highlights (unaudited)


(dollars in thousands, except per share data)


Three Months Ended


3/31/2025


12/31/2024


9/30/2024


6/30/2024


3/31/2024


GAAP Financial Measurements:

GAAP Net income (loss)

$

(6,974)

$

6,186

$

3,424

$

3,185

$

2,548

Adjustments to net income:

Loss on sales of securities

12,425

Gain on sale of fixed assets

(3,874)

Tax effect of adjustments to net income

(2,609)

813

Non-GAAP Net income

$

2,842

$

3,125

$

3,424

$

3,185

$

2,548

GAAP Noninterest income (loss)

$

(8,554)

$

8,521

$

5,251

$

4,305

$

3,480

Adjustments to noninterest income:

Loss on sales of securities

12,425

Gain on sale of fixed assets

(3,874)

Non-GAAP Noninterest income

$

3,871

$

4,647

$

5,251

$

4,305

$

3,480

Earnings per share, basic and diluted

$

(1.53)

$

1.74

$

0.97

$

0.89

$

0.72

Effect of adjustments to net income

2.15

(0.86)

Non-GAAP Earnings per share, basic and diluted

$

0.62

$

0.88

$

0.97

$

0.89

$

0.72

Annualized return on average equity

-20.75

%

21.10

%

11.99

%

11.76

%

9.53

%

Effect of adjustments to net income

29.21

%

-10.44

%

Non-GAAP Annualized return on average equity

8.46

%

10.66

%

11.99

%

11.76

%

9.53

%

Annualized return on average assets

-1.48

%

1.32

%

0.75

%

0.72

%

0.58

%

Effect of adjustments to net income

2.07

%

-0.65

%

Non-GAAP Annualized return on average assets

0.59

%

0.67

%

0.75

%

0.72

%

0.58

%

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/eagle-financial-services-inc-announces-2025-first-quarter-financial-results-and-quarterly-dividend-302438645.html

SOURCE Eagle Financial Services, Inc.

Cadence Bank Announces 2025 Share Repurchase Program

PR Newswire


HOUSTON and TUPELO, Miss.
, April 25, 2025 /PRNewswire/ — Cadence Bank’s (NYSE: CADE) (Cadence) Board of Directors authorized a new share repurchase program (the “Repurchase Program”) allowing the company to purchase up to an aggregate of 10 million shares of Cadence’s common stock. The Repurchase Program is subject to and will be effective upon approval from the Federal Reserve, and will expire on December 31, 2025.

Under the Repurchase Program, Cadence’s shares may be purchased periodically in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in accordance with federal securities laws. The Repurchase Program may be extended, modified, amended, suspended or discontinued at any time at the discretion of Cadence’s Board of Directors and does not commit Cadence to repurchase shares of its common stock. With respect to repurchases made pursuant to the Repurchase Program, the actual means of purchase, the timing of purchases, the target number of shares per purchase and the maximum price or range of prices per purchase will be determined by management in its discretion, and will depend upon a number of factors, including Cadence’s capital position, liquidity, financial performance and alternate uses of capital, the market price of Cadence’s common stock, general market and economic conditions, and applicable legal and regulatory requirements.

To learn more, visit CadenceBank.com.

About Cadence Bank  

Cadence Bank (NYSE: CADE) is a $50 billion regional financial services company committed to helping people, companies and communities prosper. With more than 350 locations spanning the South and Texas, Cadence offers comprehensive banking, investment, trust and mortgage products and services to meet the needs of individuals, businesses and corporations. Accolades include being recognized as one of the nation’s best employers by Forbes and U.S. News & World Report and a as 2025 America’s Best Banks by Forbes. Cadence maintains corporate offices in Houston, Texas and Tupelo, Mississippi, and has dutifully served customers for nearly 150 years. Learn more at www.cadencebank.com. Cadence Bank, Member FDIC. Equal Housing Lender.

Forward-Looking Statements

Certain statements made in this news release are not statements of historical fact and constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995 and the “bespeaks caution” doctrine.  These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “assume,” “believe,” “budget,” “contemplate,” “continue,” “could,” “expect,” “foresee,” “goal,” “indicate,” “may,” “might,” “outlook,” “plan,” “project,” “prospect,” “potential,” “roadmap,” “should,” “target,” “will,” “would,” or the negative version of those words, or other comparable words of a future or forward-looking nature. These forward-looking statements include, without limitation, statements related to the terms, timing, logistics and conditions of Cadence’s share repurchase programs, Cadence’s utilization of the share repurchase programs, and Cadence’s compliance with applicable law including, but not limited to, federal securities laws, in connection with the administration of the share repurchase programs.

These forward-looking statements are not historical facts, and are based upon current expectations, estimates, and projections about Cadence’s industry, management’s beliefs, and certain assumptions made by management, many of which, by their nature, are inherently uncertain, involve risk, and are beyond Cadence’s control.  The inclusion of these forward-looking statements should not be regarded as a representation by Cadence or any other person that such expectations, estimates, or projections will be achieved.  Accordingly, Cadence cautions that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and that are beyond Cadence’s control. Although Cadence believes these forward-looking statements are reasonable as of the date of this news release, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. Undue reliance should not be placed on any such forward-looking statements.

Any forward-looking statement speaks only as of the date of this news release, and Cadence does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by applicable law.  New risks and uncertainties may emerge from time to time, and it is not possible for Cadence to predict their occurrence or how they will affect Cadence.  The foregoing should be read in conjunction with those risk factors that are set forth from time to time in Cadence’s periodic and current reports filed with its primary federal regulator, including those factors included in Cadence’s Annual Report on Form 10-K for the year ended December 31, 2024 under the heading “Item 1A. Risk Factors,” in Cadence’s Quarterly Reports on Form 10-Q under the heading “Part II-Item 1A. Risk Factors,” in Cadence’s Current Reports on Form 8-K.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cadence-bank-announces-2025-share-repurchase-program-302438693.html

SOURCE Cadence Bank

Stanley Black & Decker Announces 2nd Quarter 2025 Dividend

PR Newswire


NEW BRITAIN, Conn.
, April 25, 2025 /PRNewswire/ — Stanley Black & Decker (NYSE: SWK), a worldwide leader in Tools and Outdoor, announced today that its Board of Directors approved a regular second quarter cash dividend of $0.82 per common share. This extends the Company’s record for the longest consecutive annual and quarterly dividend payments among industrial companies listed on the New York Stock Exchange. The dividend is payable on Tuesday, June 17, 2025, to shareholders of record as of the close of business on Tuesday, June 3, 2025.

About Stanley Black & Decker

Founded in 1843 and headquartered in the USA, Stanley Black & Decker (NYSE: SWK) is a worldwide leader in Tools and Outdoor, operating manufacturing facilities globally. The Company’s approximately 48,000 employees produce innovative end-user inspired power tools, hand tools, storage, digital jobsite solutions, outdoor and lifestyle products, and engineered fasteners to support the world’s builders, tradespeople and DIYers. The Company’s world class portfolio of trusted brands includes DEWALT®, CRAFTSMAN®, STANLEY®, BLACK+DECKER®, and Cub Cadet®. To learn more visit: www.stanleyblackanddecker.com or follow Stanley Black & Decker on Facebook, Instagram, LinkedIn and X.


Stanley Black & Decker Investor Contacts

Dennis Lange

Christina Francis

Vice President, Investor Relations

Director, Investor Relations


[email protected]


[email protected]

(860) 827-3833

(860) 438-3470

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/stanley-black–decker-announces-2nd-quarter-2025-dividend-302438664.html

SOURCE Stanley Black & Decker, Inc.

New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis

FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of patients with cutaneous and uveal melanoma (CM and UM, respectively) via poster presentations at the American Association for Cancer Research® (AACR) Annual Meeting 2025, being held April 25-30 in Chicago.

“At Castle Biosciences, our commitment to advancing care for melanoma patients helps drive our continuous innovation,” said Rebecca Critchley-Thorne, Ph.D., vice president, research and development, of Castle Biosciences. “The new data being presented at AACR underscores this commitment and further advances our mission to improve health through innovative tests that can help guide personalized treatment strategies designed to enhance patient outcomes.”

Castle will present the following posters at AACR (all times Central Time). The corresponding abstracts are available on AACR’s website using the inline links below.

DecisionDx-Melanoma

  • Abstract 3344: The 31-gene expression profile identifies patients at risk of developing early distant metastases and can guide risk-appropriate surveillance strategies
  • Lead Author and Presenter: Merve Hasanov, M.D., oncologist and director of the division of medical oncology at The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
  • Session Category: Clinical Research
  • Session Title: Prognostic Biomarkers 2
  • Location: Poster Section 32
  • Poster Board Number: 14
  • Date & Time: April 28, 2-5 p.m.
  • Summary: Building on findings presented at ASCO 2024, this study demonstrates that DecisionDx-Melanoma can identify early-stage CM patients (American Joint Committee on Cancer (AJCC) stage I-II, n=1,661) at higher risk of distant metastasis (DM) not only to the central nervous system (CNS), but also to the lung, liver and bone. Patients with Class 2B (highest risk) results showed significantly higher DM rates compared to Class 1A (lowest risk) patients across all sites: CNS (7.4% vs. 0.9%, p<0.001), lung (7.4% vs. 1.2%, p<0.001), liver (4.5% vs. 0.6%, p<0.001) and bone (3.0% vs. 0.8%, p<0.05). Notably, Class 2B patients had significantly lower five-year DM-free survival and elevated metastasis risk persisted several years after diagnosis, particularly to CNS and lung. These results support combining DecisionDx-Melanoma with AJCC staging to potentially identify high-risk patients for tailored surveillance and treatment strategies, which may enable earlier metastasis detection and potentially improve survival outcomes.

DecisionDx-UM

  • Abstract LB262: Development of a clinically feasible aqueous proteomic signature to assess the malignant potential of small uveal melanocytic tumors
  • Session Title: Late-Breaking Research: Clinical Research 2 / Endocrinology
  • Location: Poster Section 51
  • Poster Board Number: 11
  • Date & Time: April 29, 9 a.m.-12 p.m.
  • Summary: UM, though rare, is the most common eye cancer, with up to 50% of patients developing metastatic disease. While tumor biopsy-based molecular testing is widely utilized to identify high-risk biology, repeated intraocular tumor biopsies are not feasible for monitoring small uveal melanocytic tumors of indeterminate malignant potential (UMTIMP). This study seeks to address this unmet clinical need by evaluating aqueous humor (AH) protein biomarkers—obtainable through a minimally invasive office-based liquid biopsy from the anterior chamber of the eye—to help identify high-risk lesions early to help inform the decision to biopsy. Among 79 UM patients assessed with the DecisionDx-UM test (the current standard of care for evaluating metastatic risk in UM), 72% (57/79) were classified as low risk (Class 1) and 28% (22/79) as high risk for developing metastasis. The study identified proteins in the AH with significant differences between risk classes (N=386, p<0.0001) for the development of several risk prediction models. The proteins from the highest-performing models may be further evaluated for their ability to detect high-risk UMTIMPs with a goal of enabling more timely clinical decisions, determining the need for further prognostic testing (DecisionDx-UM, -PRAME, -UMSeq), and potentially allowing for earlier therapeutic intervention to improve patient outcomes.

About DecisionDx-Melanoma

DecisionDx-Melanoma is a 31-gene expression profile (31-GEP) risk stratification test. It is designed to inform two clinical questions in the management of cutaneous melanoma: a patient’s individual risk of sentinel lymph node (SLN) positivity and a patient’s personal risk of melanoma recurrence and/or metastasis. By integrating tumor biology with clinical and pathologic factors using a validated proprietary algorithm, DecisionDx-Melanoma is designed to provide a comprehensive and clinically actionable result to guide risk-aligned patient care. DecisionDx-Melanoma has been shown to be associated with improved patient survival and has been studied in more than 10,000 patient samples. DecisionDx-Melanoma’s clinical value is supported by more than 50 peer-reviewed and published studies, providing confidence in disease management plans that incorporate the test’s results. Through Dec. 31, 2024, DecisionDx-Melanoma has been ordered more than 191,000 times for patients diagnosed with cutaneous melanoma. Learn more at www.CastleBiosciences.com.

About DecisionDx-UM

DecisionDx-UM is Castle Biosciences’ 15-gene expression profile (15-GEP) test that uses an individual patient’s tumor biology to predict individual risk of metastasis in patients with uveal melanoma (UM). DecisionDx-UM is the standard of care in the management of newly diagnosed UM in the majority of ocular oncology practices in the United States. Since 2009, the American Joint Committee on Cancer (AJCC; v7 and v8) Staging Manual for UM has specifically identified the GEP test as a prognostic factor that is recommended for collection as a part of clinical care. Further, the National Comprehensive Cancer Network (NCCN) guidelines for UM include the DecisionDx-UM test result as a prognostic method for determining risk of metastasis and recommended differential surveillance regimens based on a Class 1A, 1B and 2 result. DecisionDx-UM is currently the only prognostic test for UM that has been validated in prospective, multi-center studies, and it has been shown to be a superior predictor of metastasis compared to other prognostic factors, such as chromosome 3 status, mutational status, AJCC stage and cell type. It is estimated that nearly 8 in 10 patients diagnosed with UM in the United States receive the DecisionDx-UM test as part of their diagnostic workup. Learn more at www.CastleBiosciences.com.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements concerning: the ability of DecisionDx-Melanoma to identify early-stage melanoma patients at high risk of DM to enable risk-appropriate surveillance and treatment; Castle’s ability to continuously innovate; the ability of new data to further advance Castle’s mission to improve health through innovative tests that can help guide personalized treatment strategies designed to enhance patient outcomes; the ability of Castle’s tests to enable more personalized treatment and improve patient outcomes; the ability of DecisionDx-Melanoma, combined with AJCC staging, to identify high-risk patients and enable earlier metastasis detection and improve survival outcomes; and the ability of the DecisionDx-UM test to detect high risk UMTIMP’s and to allow earlier therapeutic intervention to improve patient outcomes. The words “believe,” “can” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation: subsequent study or trial results and findings may contradict earlier study or trial results and findings or may not support the results obtained in these studies, including with respect to the discussion of our tests in this press release; actual application of our tests may not provide the aforementioned benefits to patients; and the risks set forth under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, and in our other filings with the SEC. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements, except as may be required by law.

Investor Contact:

Camilla Zuckero
[email protected]

Media Contact:

Allison Marshall
[email protected]